MCMC
ADAP
Matrix Capital Management Company’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-37,681,515
| Closed | -$35.8M | – | 6 |
|
|
2024
Q3 | $35.8M | Sell |
37,681,515
-1,292,670
| -3% | -$1.23M | 1.71% | 6 |
|
|
2024
Q2 | $38M | Hold |
38,974,185
| – | – | 0.29% | 20 |
|
|
2024
Q1 | $61.6M | Hold |
38,974,185
| – | – | 0.57% | 15 |
|
|
2023
Q4 | $30.9M | Hold |
38,974,185
| – | – | 0.32% | 17 |
|
|
2023
Q3 | $30.4M | Hold |
38,974,185
| – | – | 0.36% | 17 |
|
|
2023
Q2 | $36.1M | Hold |
38,974,185
| – | – | 0.42% | 16 |
|
|
2023
Q1 | $42.5M | Hold |
38,974,185
| – | – | 0.58% | 15 |
|
|
2022
Q4 | $56.9M | Hold |
38,974,185
| – | – | 1.09% | 14 |
|
|
2022
Q3 | $41.9M | Hold |
38,974,185
| – | – | 0.8% | 19 |
|
|
2022
Q2 | $66.3M | Hold |
38,974,185
| – | – | 1.5% | 14 |
|
|
2022
Q1 | $80.3M | Hold |
38,974,185
| – | – | 0.96% | 21 |
|
|
2021
Q4 | $146M | Hold |
38,974,185
| – | – | 1.63% | 16 |
|
|
2021
Q3 | $201M | Hold |
38,974,185
| – | – | 2.29% | 17 |
|
|
2021
Q2 | $166M | Hold |
38,974,185
| – | – | 1.81% | 18 |
|
|
2021
Q1 | $207M | Hold |
38,974,185
| – | – | 2.39% | 16 |
|
|
2020
Q4 | $210M | Hold |
38,974,185
| – | – | 2.27% | 17 |
|
|
2020
Q3 | $311M | Hold |
38,974,185
| – | – | 4.13% | 10 |
|
|
2020
Q2 | $390M | Buy |
38,974,185
+4,545,455
| +13% | +$45.5M | 6.08% | 7 |
|
|
2020
Q1 | $93.6M | Buy |
34,428,730
+6,428,730
| +23% | +$17.5M | 2.39% | 15 |
|
|
2019
Q4 | $33.6M | Hold |
28,000,000
| – | – | 0.72% | 19 |
|
|
2019
Q3 | $42.3M | Hold |
28,000,000
| – | – | 1.04% | 16 |
|
|
2019
Q2 | $113M | Hold |
28,000,000
| – | – | 2.08% | 17 |
|
|
2019
Q1 | $120M | Buy |
28,000,000
+851,000
| +3% | +$3.66M | 3.21% | 12 |
|
|
2018
Q4 | $156M | Buy |
27,149,000
+6,786,989
| +33% | +$39M | 5.17% | 8 |
|
|
2018
Q3 | $276M | Buy |
20,362,011
+6,278,500
| +45% | +$85.1M | 6.82% | 5 |
|
|
2018
Q2 | $167M | Buy |
14,083,511
+201,500
| +1% | +$2.39M | 4.75% | 8 |
|
|
2018
Q1 | $156M | Buy |
13,882,011
+1,668,500
| +14% | +$18.7M | 5.42% | 8 |
|
|
2017
Q4 | $81.6M | Buy |
12,213,511
+170,000
| +1% | +$1.14M | 2.91% | 12 |
|
|
2017
Q3 | $98.6M | Buy |
12,043,511
+3,351,428
| +39% | +$27.4M | 3.15% | 13 |
|
|
2017
Q2 | $39M | Buy |
+8,692,083
| New | +$39M | 1.33% | 16 |
|